Cargando…

O-12: BUILDING LOCAL CAPACITY FOR HYDROXYUREA PHARMACOKINETICS AND PRECISION DOSING IN LOW-RESOURCE SETTINGS

Detalles Bibliográficos
Autores principales:	L., SMART, M., CHARLES, A., POWER-HAYS, T., HOWARD, K., MCELHINNEY, E., AMBROSE, R., WARE
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426827/ http://dx.doi.org/10.1097/01.HS9.0000872856.73605.c8

Ejemplares similares

Hydroxyurea pharmacokinetics and precision dosing in low-resource settings
por: Smart, Luke R., et al.
Publicado: (2023)

O-01: HYDROXYUREA REDUCES THE TRANSFUSION BURDEN IN CHILDREN WITH SICKLE CELL ANEMIA IN SUB-SAHARAN AFRICA: THE REACH EXPERIENCE
por: A., POWER-HAYS, et al.
Publicado: (2022)

P-039: ALTERNATIVE DOSING AND PREVENTION OF TRANSFUSIONS (ADAPT): A PROSPECTIVE TRIAL EVALUATING TRANSFUSION UTILIZATION AND THE FEASIBILITY OF PHARMACOKINETIC HYDROXYUREA DOSING IN CHILDREN WITH SICKLE CELL ANEMIA IN UGANDA
por: POWER-HAYS, A., et al.
Publicado: (2022)

S129: IMPLEMENTATION OF HYDROXYUREA THERAPY FOR SICKLE CELL DISEASE ON A LARGE SCALE IN GHANA
por: Ohene-Frempong, K, et al.
Publicado: (2022)

5595849 THE GUT MICROBIOME AND HYDROXYUREA EFFECT ON SICKLE CELL DISEASE CHILDREN FROM ANGOLA
por: Brito, M., et al.
Publicado: (2023)

Equipping missionaries for the mission: capacity building initiatives and the decentralised planning in Jharkhand, India
por: Prasad, Suranjeen, et al.
Publicado: (2012)

Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia
por: Rankine-Mullings, Angela, et al.
Publicado: (2023)

S269: MALE PATIENTS WITH SCD HAVE A HIGHER RISK OF CEREBROVASCULAR DISEASE, INCREASED INFLAMMATORY MARKERS, AND POORER RESPONSE TO HYDROXYUREA
por: DI Mauro, Margherita, et al.
Publicado: (2023)

Building up resources and knowledge to unravel transcriptomics dynamics underlying Eucalyptus globulus xylogenesis
por: Paiva, Jorge AP, et al.
Publicado: (2011)

S212: A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF JAKTINIB VERSUS HYDROXYUREA IN PATIENTS WITH INTERMEDIATE-2 OR HIGH RISK MYELOFIBROSIS
por: Zhang, Yi, et al.
Publicado: (2023)

Optimizing Hydroxyurea Treatment for Sickle Cell Disease Patients: The Pharmacokinetic Approach
por: Nazon, Charlotte, et al.
Publicado: (2019)

Building workforce capacity to operate a web-based logistics management information system (LMIS) in Pakistan
por: Tariq, Muhammad, et al.
Publicado: (2014)

S168: PELABRESIB (CPI-0610) MONOTHERAPY IN PATIENTS WITH HIGH-RISK ESSENTIAL THROMBOCYTHEMIA REFRACTORY OR INTOLERANT TO HYDROXYUREA: PRELIMINARY RESULTS FROM MANIFEST STUDY
por: Passamonti, Francesco, et al.
Publicado: (2023)

Strengthening the capacity of and professionalizing human resources for supply chain in Indonesia through the SCM Provincial Network
por: Mas’ud, Hidayati, et al.
Publicado: (2014)

Village Health and Sanitation Committees: evaluation of a capacity-building intervention in Bagalkot and Koppal districts of Northern Karnataka
por: Mohan, HL, et al.
Publicado: (2012)

Population pharmacokinetics and pharmacodynamics of hydroxyurea in sickle cell anemia patients, a basis for optimizing the dosing regimen
por: Paule, Ines, et al.
Publicado: (2011)

Effectiveness of Pharmacokinetic-Guided Hydroxyurea Dose Individualization in Patients with Sickle Cell Anemia: A Mini-Review
por: dos Santos Neres, Joelma Santana, et al.
Publicado: (2023)

Building sustainable organizational capacity to deliver HIV programs in resource-constrained settings: stakeholder perspectives
por: Sharma, Anjali, et al.
Publicado: (2013)

Exploring challenges of RCTs in the emergency and critical care setting
por: Mouncey, Paul, et al.
Publicado: (2015)

Building the capacity of Sierra Leoneans in supply chain on the National Pharmaceutical Procurement Unit (NPPU) project (a case study)
por: Juma, Maurice, et al.
Publicado: (2014)

Assessing health systems in low-resource settings: some conceptual and methodological dilemmas
por: Balabanova, Dina
Publicado: (2014)

Acute chest syndrome and COVID‐19 in hydroxyurea naïve sickle cell disease patient in a low resource setting
por: Mawalla, William Frank, et al.
Publicado: (2022)

Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing Regimens
por: Teigen, David, et al.
Publicado: (2023)

Management of epilepsy in resource-limited settings: establishing an epileptic surgery program in Southern Iran
por: Asadi-Pooya, Ali Akbar, et al.
Publicado: (2012)

S105: ADDING AZATHIOPRINE/HYDROXYUREA PRECONDITIONING TO ALEMTUZUMAB/TBI CONDITIONING IMPROVES DONOR CHIMERISM IN MATCHED SIBLING DONOR STEM CELL TRANSPLANTATION IN ADULT SICKLE CELL DISEASE PATIENTS
por: Dovern, E, et al.
Publicado: (2022)

Development of a technical assistance framework for building organizational capacity of health programs in resource-limited settings
por: Reyes, E Michael, et al.
Publicado: (2014)

Partnering to build surgical capacity in low-resource settings: a qualitative study of Canadian global surgeons
por: Khalid, Muhammad Uzair, et al.
Publicado: (2023)

Effect of Concomitant Hydroxyurea Therapy with Rutin and Gallic Acid: Integration of Pharmacokinetic and Pharmacodynamic Approaches
por: Gour, Abhishek, et al.
Publicado: (2021)

P-047: PROSPECTIVE IDENTIFICATION OF VARIABLES AS OUTCOMES FOR TREATMENT (PIVOT): A PHASE II CLINICAL TRIAL OF HYDROXYUREA FOR CHILDREN AND ADULTS WITH HBSC DISEASE
por: L., SMART, et al.
Publicado: (2022)

Using cost-effectiveness analysis to support decision making in resource poor settings: methods and practical challenges
por: Sculpher, Mark
Publicado: (2014)

15. Utilization of Augmented Reality Smart Glasses for the Provision of Remote Surgical Training in the Resource-Constrained Setting
por: Turk, Marvee, et al.
Publicado: (2022)

What's wrong with capacity? Capacity as the test of compulsion
por: Bartlett, Peter
Publicado: (2007)

763. Infection Prevention Resource Physicians to Build On-Call Capacity
por: Hayes, Ericka, et al.
Publicado: (2023)

Implementation of the therapeutic use of hydroxyurea for sickle cell disease management in resource-constrained settings: a systematic review of adoption, cost and acceptability
por: Ryan, Nessa, et al.
Publicado: (2020)

The pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers
por: Ashby, J, et al.
Publicado: (2010)

Editorial: Oral Oncology: From Precise Surgery to Precision Medicine and Surgery
por: Saidak, Zuzana, et al.
Publicado: (2022)

The Crossroads of Periodontitis and Oral Squamous Cell Carcinoma: Immune Implications and Tumor Promoting Capacities
por: Elebyary, Omnia, et al.
Publicado: (2021)

Deep Machine Learning for Oral Cancer: From Precise Diagnosis to Precision Medicine
por: Alabi, Rasheed Omobolaji, et al.
Publicado: (2022)

Building Clinical Clerkships Capacity in a Resource-limited Setting: The Case of the Kilimanjaro Christian Medical University College in Tanzania
por: Tarimo, Chrispina N., et al.
Publicado: (2018)

Building local capacity for cervical cancer prevention in low resource settings: Changing strategy during the COVID-19 pandemic
por: Salcedo, Mila P, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q1dq6pob7n94bbr371r8okv1cg